Skip to main content
Top
Published in: Cancer Causes & Control 3/2019

01-03-2019 | Brief report

Racial disparities in eligibility for low-dose computed tomography lung cancer screening among older adults with a history of smoking

Authors: Chien-Ching Li, Alicia K. Matthews, Mantle M. Rywant, Emily Hallgren, Raj C. Shah

Published in: Cancer Causes & Control | Issue 3/2019

Login to get access

Abstract

Purpose

Lung cancer early detection screening has been demonstrated to decrease lung cancer mortality among high-risk smokers. This study aimed to examine whether current screening guidelines may disproportionately exclude African American smokers who are at higher overall risk for lung cancer.

Methods

Data from the 2014 Health and Retirement Study were analyzed. Older African Americans and Whites with a history of smoking were included in the analyses (n = 7,348). Eligibility criteria established by the U.S. Preventive Services Task Force (USPSTF) for LDCT lung cancer screening were used. Multivariate logistic regression analyses were conducted to examine racial differences in eligibility for LDCT lung cancer screening.

Results

Overall, 21.1% of current and 10.5% of former smokers met USPSTF’s eligibility criteria for LDCT screening. In multivariate logistic regression analyses, African American smokers were less likely to be eligible for LDCT lung cancer screening compared to Whites (odds ratio = 0.5; p < 0.001).

Conclusion

African American smokers were less likely to meet established lung cancer screening eligibility criteria compared to Whites. Current lung cancer screening criteria may not adequately capture African Americans at risk and may widen the health disparities in African Americans. Further longitudinal studies are needed to evaluate the efficacy of current lung cancer screening guideline.
Literature
1.
go back to reference American Cancer Society (2016) Cancer facts & figs. American Cancer Society, Atlanta American Cancer Society (2016) Cancer facts & figs. American Cancer Society, Atlanta
2.
go back to reference US Department of Health Human Services (2014) The health consequences of smoking—50 years of progress. A report of the Surgeon General US Department of Health Human Services (2014) The health consequences of smoking—50 years of progress. A report of the Surgeon General
3.
go back to reference Centers for Disease Control and Prevention (2016) Cigarette smoking among adults—United States, 2005–2015. Morb Mortal Wkly Rep 65(44):1205–1211 Centers for Disease Control and Prevention (2016) Cigarette smoking among adults—United States, 2005–2015. Morb Mortal Wkly Rep 65(44):1205–1211
4.
go back to reference Howlader N, Krapcho M, Miller D et al (2016) SEER cancer statistics review, 1975–2013. National Cancer Institute, Bethesda Howlader N, Krapcho M, Miller D et al (2016) SEER cancer statistics review, 1975–2013. National Cancer Institute, Bethesda
5.
go back to reference American Lung Association (2015) Too many cases, too many deaths: lung cancer in African Americans. American Lung Association, Washington American Lung Association (2015) Too many cases, too many deaths: lung cancer in African Americans. American Lung Association, Washington
6.
go back to reference Mulligan CR, Meram AD, Proctor CD, Wu H, Zhu K, Marrogi AJ (2006) Unlimited access to care: effect on racial disparity and prognostic factors in lung cancer. Cancer Epidemiol Prev Biomark 15:25–31CrossRef Mulligan CR, Meram AD, Proctor CD, Wu H, Zhu K, Marrogi AJ (2006) Unlimited access to care: effect on racial disparity and prognostic factors in lung cancer. Cancer Epidemiol Prev Biomark 15:25–31CrossRef
7.
go back to reference Morello-Frosch R, Jesdale BM (2006) Separate and unequal: residential segregation and estimated cancer risks associated with ambient air toxics in US metropolitan areas. Environ Health Perspect 114:386CrossRefPubMed Morello-Frosch R, Jesdale BM (2006) Separate and unequal: residential segregation and estimated cancer risks associated with ambient air toxics in US metropolitan areas. Environ Health Perspect 114:386CrossRefPubMed
8.
go back to reference Ford JG, Howerton MW, Lai GY et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112:228–242CrossRefPubMed Ford JG, Howerton MW, Lai GY et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112:228–242CrossRefPubMed
9.
go back to reference Association AL (2016) Providing guidance on lung cancer screening to patients and physicians. An update from the American Lung Association Screening Committee. 30 April 2015 Association AL (2016) Providing guidance on lung cancer screening to patients and physicians. An update from the American Lung Association Screening Committee. 30 April 2015
10.
go back to reference National Lung Screening Trial Research Team (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395CrossRef National Lung Screening Trial Research Team (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395CrossRef
11.
go back to reference Tanner NT, Gebregziabher M, Hughes Halbert C, Payne E, Egede LE, Silvestri GA (2015) Racial differences in outcomes within The National Lung Screening Trial. Implications for widespread implementation. Am J Respir Critical Care Med 192:200–208CrossRef Tanner NT, Gebregziabher M, Hughes Halbert C, Payne E, Egede LE, Silvestri GA (2015) Racial differences in outcomes within The National Lung Screening Trial. Implications for widespread implementation. Am J Respir Critical Care Med 192:200–208CrossRef
12.
go back to reference Moyer VA (2014) Screening for lung cancer: US Preventive Services Task Force recommendation statement. Ann Internal Med 160:330–338 Moyer VA (2014) Screening for lung cancer: US Preventive Services Task Force recommendation statement. Ann Internal Med 160:330–338
13.
go back to reference Medicare Cf, Services M (2015) Decision memo for screening for lung cancer with low dose computed tomography (LDCT)(CAG-00439N) Medicare Cf, Services M (2015) Decision memo for screening for lung cancer with low dose computed tomography (LDCT)(CAG-00439N)
14.
go back to reference Holford TR, Levy DT, Meza R (2016) Comparison of smoking history patterns among African American and White Cohorts in the United States born 1890 to 1990. Nicotine Tob Res 18:S16–S29CrossRefPubMedPubMedCentral Holford TR, Levy DT, Meza R (2016) Comparison of smoking history patterns among African American and White Cohorts in the United States born 1890 to 1990. Nicotine Tob Res 18:S16–S29CrossRefPubMedPubMedCentral
16.
go back to reference Ryan BM (2016) Differential eligibility of African American and European American lung cancer cases using LDCT screening guidelines. BMJ 3:e000166 Ryan BM (2016) Differential eligibility of African American and European American lung cancer cases using LDCT screening guidelines. BMJ 3:e000166
17.
go back to reference Heeringa SG, Connor JH (1995) Technical description of the Health and Retirement Survey sample design. University of Michigan, Ann ArborCrossRef Heeringa SG, Connor JH (1995) Technical description of the Health and Retirement Survey sample design. University of Michigan, Ann ArborCrossRef
18.
go back to reference RAND Center for the Study of Aging (2011) RAND HRS Data Documentation, Version K. Santa Monica, CA RAND Center for the Study of Aging (2011) RAND HRS Data Documentation, Version K. Santa Monica, CA
19.
go back to reference Pinsky PF, Kramer BS (2015) Lung cancer risk and demographic characteristics of current 20–29 pack-year smokers: implications for screening. J Natl Cancer Inst 107:djv226CrossRefPubMedPubMedCentral Pinsky PF, Kramer BS (2015) Lung cancer risk and demographic characteristics of current 20–29 pack-year smokers: implications for screening. J Natl Cancer Inst 107:djv226CrossRefPubMedPubMedCentral
20.
go back to reference Nemesure B, Plank A, Reagan L, Albano D, Reiter M, Bilfinger TV (2017) Evaluating efficacy of current lung cancer screening guidelines. J Med Screen 24:208–213CrossRefPubMed Nemesure B, Plank A, Reagan L, Albano D, Reiter M, Bilfinger TV (2017) Evaluating efficacy of current lung cancer screening guidelines. J Med Screen 24:208–213CrossRefPubMed
21.
go back to reference Control CFD, Prevention (2011) Quitting smoking among adults–United States, 2001–2010. MMWR 60:1513 Control CFD, Prevention (2011) Quitting smoking among adults–United States, 2001–2010. MMWR 60:1513
22.
go back to reference Haiman CA, Stram DO, Wilkens LR et al (2006) Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med 354:333–342CrossRefPubMed Haiman CA, Stram DO, Wilkens LR et al (2006) Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med 354:333–342CrossRefPubMed
23.
go back to reference Robbins HA, Engels EA, Pfeiffer RM, Shiels MS (2015) Age at cancer diagnosis for blacks compared with whites in the United States. JNCI 107(3):dju489CrossRefPubMed Robbins HA, Engels EA, Pfeiffer RM, Shiels MS (2015) Age at cancer diagnosis for blacks compared with whites in the United States. JNCI 107(3):dju489CrossRefPubMed
24.
go back to reference Schwartz AG, Swanson GM (1997) Lung carcinoma in African Americans and whites: a population-based study in metropolitan Detroit, Michigan. Cancer 79:45–52CrossRefPubMed Schwartz AG, Swanson GM (1997) Lung carcinoma in African Americans and whites: a population-based study in metropolitan Detroit, Michigan. Cancer 79:45–52CrossRefPubMed
25.
go back to reference Fiscella K, Winters P, Farah S, Sanders M, Mohile SG (2015) Do lung cancer eligibility criteria align with risk among blacks and hispanics? PLoS ONE 10: e0143789CrossRefPubMedPubMedCentral Fiscella K, Winters P, Farah S, Sanders M, Mohile SG (2015) Do lung cancer eligibility criteria align with risk among blacks and hispanics? PLoS ONE 10: e0143789CrossRefPubMedPubMedCentral
26.
go back to reference Tammemägi MC (2015) Application of risk prediction models to lung cancer screening: a review. J. Thorac. Imaging 30:88–100CrossRefPubMed Tammemägi MC (2015) Application of risk prediction models to lung cancer screening: a review. J. Thorac. Imaging 30:88–100CrossRefPubMed
28.
go back to reference Katki HA, Kovalchik SA, Berg CD, Cheung LC, Chaturvedi AK (2016) Development and validation of risk models to select ever-smokers for CT lung cancer screening. Jama 315:2300–2311CrossRefPubMedPubMedCentral Katki HA, Kovalchik SA, Berg CD, Cheung LC, Chaturvedi AK (2016) Development and validation of risk models to select ever-smokers for CT lung cancer screening. Jama 315:2300–2311CrossRefPubMedPubMedCentral
29.
go back to reference Etzel CJ, Kachroo S, Liu M et al (2008) Development and validation of a lung cancer risk prediction model for African-Americans. Cancer Prev Res 1:255–265CrossRef Etzel CJ, Kachroo S, Liu M et al (2008) Development and validation of a lung cancer risk prediction model for African-Americans. Cancer Prev Res 1:255–265CrossRef
Metadata
Title
Racial disparities in eligibility for low-dose computed tomography lung cancer screening among older adults with a history of smoking
Authors
Chien-Ching Li
Alicia K. Matthews
Mantle M. Rywant
Emily Hallgren
Raj C. Shah
Publication date
01-03-2019
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 3/2019
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-018-1092-2

Other articles of this Issue 3/2019

Cancer Causes & Control 3/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine